Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma
- PMID: 34771617
- PMCID: PMC8582560
- DOI: 10.3390/cancers13215454
Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma
Abstract
(1) Background: Prognostic grade group (PGG) is an important prognostic parameter in prostate cancer that guides therapeutic decisions. The cribriform pattern and intraductal carcinoma (IDC) are two histological patterns, that have additional prognostic significance. However, discrepancies exist regarding the handling of IDC according to the guidelines published by two international genitourinary pathology societies. Furthermore, whether, in addition to its presence, the amount of IDC is also of importance has not been studied before. Lastly, the handling of tertiary patterns has also been a matter of debate in the literature. (2) Methods: A total of 129 prostatectomy cases were retrieved and a detailed histopathologic analysis was performed. (3) Results: Two cases (1.6%) upgraded their PGG, when IDC was incorporated in the grading system. The presence and the amount of IDC, as well as the presence of cribriform carcinoma were associated with adverse pathologic characteristics. Interestingly, in six cases (4.7%) there was a difference in PGG when using the different guidelines regarding the handling of tertiary patterns. In total, 6.2% of the cases would be assigned a different grade depending on the guidelines followed. (4) Conclusions: These findings highlight a potential area of confusion among pathologists and clinicians and underscore the need for a consensus grading system.
Keywords: Gleason Score; cribriform pattern; intraductal carcinoma; prognostic grade group.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493. doi: 10.5858/arpa.2020-0015-RA. Arch Pathol Lab Med. 2021. PMID: 32589068 Review.
-
Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.Eur J Cancer. 2014 Jun;50(9):1610-6. doi: 10.1016/j.ejca.2014.03.009. Epub 2014 Apr 3. Eur J Cancer. 2014. PMID: 24703897
-
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1. Prostate. 2017. PMID: 28144985
-
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820. Am J Surg Pathol. 2017. PMID: 28177964
-
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530. Am J Surg Pathol. 2016. PMID: 26492179 Review.
Cited by
-
Prostate Cancer: Pathophysiology, Pathology and Therapy.Cancers (Basel). 2022 Dec 31;15(1):281. doi: 10.3390/cancers15010281. Cancers (Basel). 2022. PMID: 36612276 Free PMC article.
-
Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.Cancers (Basel). 2022 Jun 21;14(13):3041. doi: 10.3390/cancers14133041. Cancers (Basel). 2022. PMID: 35804812 Free PMC article. Review.
-
Intraductal Carcinoma of the Prostate: To Grade or Not to Grade.Cancers (Basel). 2023 Nov 7;15(22):5319. doi: 10.3390/cancers15225319. Cancers (Basel). 2023. PMID: 38001579 Free PMC article. Review.
-
DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology.Int J Mol Sci. 2023 Jul 13;24(14):11418. doi: 10.3390/ijms241411418. Int J Mol Sci. 2023. PMID: 37511177 Free PMC article. Review.
-
Predicting prostate adenocarcinoma patients' survival and immune signature: a novel risk model based on telomere-related genes.Discov Oncol. 2024 Jun 2;15(1):203. doi: 10.1007/s12672-024-00986-2. Discov Oncol. 2024. PMID: 38825615 Free PMC article.
References
-
- Epstein J.I., Egevad L., Amin M.B., Delahunt B., Srigley J.R., Humphrey P.A. The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system. Am. J. Surg. Pathol. 2016;40:244–252. doi: 10.1097/PAS.0000000000000530. - DOI - PubMed
-
- Humphrey P.A., Amin M.B., Berney D.M., Billis A., Cao D., Cheng L., Delahunt B., Egevad L.L., Epstein J.I., Fine S.W., et al. In: WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Moch H., Humphrey P.A., Ulbright T.M., Reuter V.E., editors. Volume 8. IARC Publications; Lyon, France: 2016.
Grants and funding
LinkOut - more resources
Full Text Sources